OSTX CIK: 1795091

OS Therapies Inc

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
0.00
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.84
FY22:
−4.45
FY23:
−4.34
FY24:
−6.81
FY25:
−28.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.84
FY22:
−4.45
FY23:
−4.34
FY24:
−6.83
FY25:
−29.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.42
FY22:
−6.25
FY23:
−7.79
FY24:
−8.88
FY25:
−28.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.42
FY22:
−6.25
FY23:
−7.79
FY24:
−8.88
FY25:
−28.8

All amounts in millions USD FY21, FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data